INTRODUCTION {#SEC1}
============

Resistance to glycopeptides, macrolides, pleuromutilins, phenicols, linezolid and other antibiotics among Gram-positive cocci is generally linked to plasmids whose copy number control, partitioning and post-segregational killing is regulated by the ω cassette ([@B1],[@B2]). This cassette contains sequences that encode the ω or ω2 gene products ([@B1]). It is thus important to understand how homodimeric ω (ω~2~) (or ω2 \[ω2~2~\]) functions, not only because of its intrinsic biological interest, but also because of its relevance to antibiotic resistance transmission ([@B1],[@B2]). Plasmids of the *inc*18 family are commonly found in *Enterococcus* and *Streptococcus*. These plasmids have a broad host range in Firmicutes. Here, ω forms an operon with ϵ and ζ. Meanwhile, ω2 forms an operon with the *ermB* gene ([@B1]).

A transcriptional analysis of few *inc*18 plasmids (e.g. pSM19035, pIP501 and pAMβ1) revealed that ω~2~ controlled the expression of the copy control gene *copS*. Also mediated by ω~2~ was the expression of plasmid partition genes, such as δ and ω, and toxin-antitoxin systems, such as the ωϵζ operon (Figure [1A](#F1){ref-type="fig"}) ([@B1]). The *inc*18 plasmids persist in the population through a variety of mechanisms controlled by ω~2~. The ω~2~ protein is a ParB homologue and binds to *parS* centromers. In concert with δ~2~ (a ParA ATPase), ω~2~ is involved in accurate plasmid partitioning and coupling plasmid replication to faithful segregation ([@B1],[@B3]--[@B5]). All three *parS* sites (Figure [1A](#F1){ref-type="fig"}) can cause partition-mediated incompatibility ([@B5]). Furthermore, toxin ζ stabilizes bacterial plasmids by programming the death of any host cell that fails to inherit a plasmid copy during cell division ([@B1],[@B6]). Toxins ζ and RelE are the most ubiquitous toxins in nature. In contrast, much less is known about the purpose of the ω2 gene product, which is truncated in some members of the family (e.g. pSM19035) (Figure [1A](#F1){ref-type="fig"}) ([@B1]).

![Interaction of ω~2~, δ~2~ or RNAP-σ^A^ with the *P*~ω~ operator sites. (**A**) Genome organization of the relevant region of plasmid pSM19035. The promoters (*P*), the mRNAs and the genes are symbolized by boxes, wavy lanes and rectangles, respectively. The plasmid replication origin (*ori*) is labelled in orange. The direction of replication is denoted by a black arrows below. Protein ω~2~-mediated transcriptional repression is indicated (ω~2~, red ovals). The upstream regions of *P~copS~, P*~δ~ and *P*~ω~ (red box) which constitute the *cis*-acting *parS* centromeric sites magnified. The ω~2~ cognate sites consist of a variable number of contiguous 7-bp heptad repeats (iterons) symbolized by ▸ (in the direct orientation) or ◂ (in the inverted orientation). The number of repeats and their relative orientations are indicated. The genes involved in replication (*copS, repS*, RNAIII and γ), dimer resolution (β), faithful partition (δ and ω), stable segregation (ϵ and ζ) are indicated. The antibiotic resistance gene *ermB* and the truncated version of ω2 ('ω2') are also indicated. (**B**) A structural model of ω~2~-bound to *P*~ω~ DNA which derived from the crystal structure of the complex of the minimal operator site and ω~2~Δ19 (PDB ID 1IRQ, 2BNW and 2BNZ). Pink/purple ω~2~ molecules form a left-handed protein-matrix winding around the nearly linear operator DNA. The DNA is represented in grey with the −35 and −10 elements in yellow. (**C**) Model of RNAP-σ^A^ which is derived from crystal structures of the homologous protein from *T. aquaticus* and *T. thermophilus* (PDB ID 1IW7, 2A6H) together with the *P*~ω~ DNA from PDB ID 2CAX. Colour coding: brown and light brown refer to α~2~; blue, β; red, β' and green, σ subunit. (**D**) Model of δ~2~ binding to DNA. The atomic coordinates of (δ·ATPγS·Mg^2+^)~2~ were taken from the 2OZE PDB entry. The modelled structures were prepared and visualized with PyMOL version 1.5.0.4. (**E**) Interactions of ω~2~ and δ~2~ with *P*~ω~ DNA and each other: 1. ω~2~ (in purple) transiently interacts with *P*~ω~ DNA forming complex C1; 2. The interaction of ω~2~ with δ~2~-apo (in grey), leads to functional transition of ω~2~ (in green) and formation of the durable C2 complex; 3. In the presence of ATP, δ~2~ (in blue) binds to C1 to generate C3. (**F**) Complexes formed by ω~2~ and RNAP-σ^A^ upon binding to *P*~ω~ DNA: 1. RNAP-σ^A^ bound to *P*~ω~ DNA forms complex RC1; 2. the interaction of RNAP-σ^A^ with limiting concentrations of ω~2~ leads to a functional transition of ω~2~ and formation of C2; and 3. RNAP-σ^A^ bound to C1 makes RC2.](gkv788fig1){#F1}

*Streptococcus pyogenes* monomeric ω (71-residue long, 7.9 kDa) has an unstructured N-terminal domain (NTD, residues 1--24) followed by a ribbon-helix-helix (RHH) fold (residues 25--71). The latter facilitates the formation, in solution, of a dimer that has a pseudo-2-fold symmetry ([@B7]--[@B9]). The RHH domain recognizes the *parS* centromers embedded in the promoter regions of the *cop*, δ, ω and ω2 genes (Figure [1A](#F1){ref-type="fig"} and Supplementary Figure S1) ([@B4]). The operator binding sites are comprised of a series of 6--10 unspaced heptad repeats (5′-^T^/~A~ATCAC^T^/~A~-3′) in a forward orientation. Alternatively, they consist of two or three repeats of the following: two heptads in a forward orientation followed by one in an inverse orientation (→→←) (Supplementary Figure S1). Both the ω~2~ and the NTD lacking ω~2~ΔN19 mutant transiently bind promoters and repress promoter utilization both *in vivo* and *in vitro* ([@B4],[@B9]--[@B13]).

The minimal ω~2~ binding site is comprised of two contiguous heptads in a forward (→→) or inverted (→←) orientation. It has higher affinity for the latter (see 10). The structure of the complex of ω~2~ bound to →→ DNA is very similar to the one of ω~2~ bound to →← DNA. In neither case does ω~2~ distort the DNA when binding to it ([@B9],[@B14]). These structures show that a pair of positively charged antiparallel β strands from ω~2~ insert into the major groove of DNA. The β strands make specific and sequence-dependent contacts with symmetric or asymmetric repetitive sequences that deviate 0.3 Å with respect to the central C-G pair of each repetition ([@B8],[@B9],[@B14]). In a full cognate site, ω~2~ is displaced ∼7-bp and rotated 252º with respect to its neighbouring dimer. The negatively charged sugar-phosphate DNA backbone faces the positively charged surface of the protein (Figure [1B](#F1){ref-type="fig"}) ([@B9]).

Protein ω~2~ transiently binds with high affinity (apparent dissociation constant \[K~Dapp~\] = 5 ± 1 nM) and cooperativity to *P*~ω~ DNA (Figure [1E](#F1){ref-type="fig"}, condition 1 \[C1\]) ([@B13]). The physical interaction of the apo form of δ~2~ with ω~2~ bound to *P*~ω~ DNA facilitates a structural transition in ω~2~ that might involve folding of its unstructured NTD (Figure [1E](#F1){ref-type="fig"}, condition 2) (see 13,15). ω~2~ stably binds *P*~ω~ DNA with high affinity (K~Dapp~ = 0.7 ± 0.1 nM), forming the C2 complex (ω~2~·*P*~ω~ DNA) (Figure [1E](#F1){ref-type="fig"}, condition 2). The C2 complex is stable, with a half-life of \>30 min, whereas the C1 complex is transient, with half-life of \<1 min ([@B10],[@B13],[@B15]). However, despite the difference in stability, C1 and C2 have a similar mobility in a PAGE at low protein concentrations.

The δ~2~ protein is a U-shaped ATPase that in its ATP-bound form, binds non-specifically to DNA (Figure [1D](#F1){ref-type="fig"}) ([@B16]). In the presence of ATP, δ~2~ interacts with C1 to form the C3 complex (Figure [1E](#F1){ref-type="fig"}, condition 3) ([@B13]). Since it lacks the unfolded NTD, ω~2~ΔN19 cannot facilitate C2 and C3 formation ([@B13]). Given that δ~2~ (a ParA ATPase) works together with ω~2~ (a ParB centromeric binding protein) bound to *parS* (e.g. *P*~ω~ DNA) to promote faithful plasmid segregation ([@B12],[@B13]), it is likely that δ~2~ also contributes to ω~2~-mediated transcription regulation.

Transcription initiation by the multisubunit RNA polymerase (RNAP) is an intricate multistep process ([@B17]--[@B20]). Bacterial RNAP exists in two forms: i) the ubiquitous core enzyme, which consists of the dimeric form of α (α~2~), the monomeric form of β, β', and one or more of small non-essential subunits; this carries out processive transcription elongation followed by termination; and ii) the RNAP-σ holoenzyme, in which a dissociable σ subunit, essential for promoter recognition, has joined the core enzyme ([@B21]--[@B23]). The *Bacillus subtilis* vegetative RNAP-σ^A^ holoenzyme binds to specific **−**10 and **−**35 promoter (*P*) elements to form an unstable closed binary complex (RP~C~) ([@B21],[@B24]--[@B27]). A RNAP-σ^A^-assisted isomerization step then occurs. This is mediated by kinetically unstable intermediates (RP~I~). This, in turn, leads to *P* melting of ∼14-bp (−12 to +2) in the DNA surrounding the transcription start site. This process yields the catalytically active, open RNAP-σ^A^·*P* DNA complex (RP~O~) ([@B17],[@B28]). The structures responsible for the functions associated with RPo formation are predominantly located in the σ, β and β' subunits of the RNAP-σ ([@B18],[@B22],[@B23],[@B25],[@B28]). In the presence of nucleotide triphosphates, an initiation complex (RP~INIT~) is formed. This complex is a prerequisite for displacement of RNAP-σ^A^ from the promoter through an elongation complex (RP~E~) ([@B24],[@B25],[@B28]). RNAP subunits δ, ϵ and ω are not essential for this process and their roles are therefore poorly understood.

As a result of the association of regulatory elements to promoter-embedded operator sequences, gene regulation is often achieved at the level of transcription initiation ([@B29]). The ω~2~ protein interacts with its cognate sites as a left-handed protein helix wrapped around a nearly linear *P*~ω~ DNA ([@B9]). In this structure the −35 and −10 elements are free to interact with RNAP-σ^A^ (Figure [1B](#F1){ref-type="fig"}, yellow regions). A model of RNAP-σ bound to *P*~ω~ DNA suggests that ω~2~ might repress transcription by steric hindrance (Figure [1C](#F1){ref-type="fig"}). However, preliminary results indicate that ω~2~ forms a ternary complex with RNAP-σ^A^ and *P~copS~* DNA ([@B4]). These data suggest that ω~2~ regulates transcription through a mechanism that does not exclude the RNAP-σ^A^ from the RP~C~. It is assumed that this mechanism also applies to *P*~ω~ and *P*~δ~. In this study, we aimed to unravel the mechanism of ω~2~-mediated transcriptional regulation of *P*~ω~ DNA, *in vitro*, and *P*~δ~ utilization, *in vivo*. We first characterized the effect that ω~2~ binding to *P*~ω~ DNA had on RNAP-σ^A^ promoter recognition. We also tested whether or not modifying the stoichiometry of ω~2~, δ~2~ and RNAP-σ^A^ resulted in variations in their affinity for *P*~ω~ DNA. Also investigated was whether or not transcription activation or repression by ω~2~ required direct contacts with RNAP-σ^A^ and δ~2~. Another important question was whether or not this binding was cooperative. Based on the results of this study, we present a model that explains how ω~2~-mediated transcriptional regulation functions.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains and plasmids {#SEC2-1}
------------------------------

The *E. coli* strains DH5α (Invitrogen) and ER2566 (New England Biolabs) and the *B. subtilis* strains BG214, BG508 ([@B4]) and NIG2001 ([@B30]) were used. The BG508 strain carries *P*~δ~ fused to a promoter-less *lacZ* gene. This construct was integrated as a unique copy into the *amyE locus* of the *B. subtilis* chromosome ([@B4]). In the NIG2001 strain, the wild-type (wt) *rpoC* gene was substituted in the *B. subtilis* genome with a version that had a His-tag coding sequence fused to the 3′-end ([@B30]). The *P*~ω~ bearing pCB30 plasmid was used for promoter analysis, and pHP14 was used for cloning purposes ([@B4]). The plasmids used for gene over-expression were pT712ω bearing ω, pCB746 bearing δ ([@B4],[@B11],[@B16]), and pT712ωD56A bearing the ωD56A gene (this work). The single mutations in the ω gene were obtained by gene synthesis (Genscript). BG508 cells bearing pHP14 carrying either the ω, δ, ωδ, ωΔN19, ω2, ωK52A, ωE53A, ωD56A, ωR64A or ωK70A genes were used for the β-galactosidase assays. The native promoters of these genes were also incorporated into the constructs.

DNA, RNA, proteins and reagents {#SEC2-2}
-------------------------------

Plasmid DNA was purified as described ([@B4]). The multiple mutations in heptads 1, 1 plus 2, 7 and 7 plus 6 were obtained by *in vitro* synthesis (Genscript). DNA restriction and modification enzymes and RNaseA were purchased from Boehringer Mannheim and the nucleotides were purchased from Sigma. Gel-purified DNA fragments were end-labelled as described ([@B4]). The amount of DNA was quantified using molar extinction coefficient of 6500 M^−1^ cm^−1^ at 260 nm and was expressed in moles of DNA molecules.

The RNAP-σ^A^ was purified using Ni-NTA and Q-sepharose columns as described ([@B30]). The ω~2~ and δ~2~ proteins were purified as described ([@B4],[@B11],[@B16]). Protein ωD56A was purified as wt ω~2~. Protein concentrations were calculated using molar extinction coefficients at 280 nm of 2980, 2980, 38 850 and 236 000 M^−1^ cm^−1^ for ω~2~, ωD56A, δ~2~, and RNAP-σ^A^, respectively. Concentrations were expressed in molarity of protein monomers for RNAP-σ^A^ and of dimers for δ~2~, ω~2~ and ω~2~ derivatives. Note that unless otherwise stated, δ~2~ is in the ATP·Mg^2+^-bound form.

*B. subtilis* BG508 harbouring different plasmids was grown to OD~600~ = ∼0.5 and aliquots were used for β-galactosidase assays ([@B4]). The cultures were pelleted and resuspended in buffer B (10 mM Na~2~HPO~4~/NaH~2~PO~4~ pH 7.2, 50 mM β-mercaptoethanol, 1 mM MgCl~2~, 10 mM KCl) containing 0.4 μg/ml lysozyme ([@B4]). After a 5 min incubation at 37ºC, the lysates were clarified by centrifugation for 5 min at 12,000 *g* and assayed for β-galactosidase activity, as described ([@B31]).

Protein cross-linking was used to study potential protein--protein interactions. For this, *bis*disuccinimidyl suberate (DSS) was employed as the crosslinking agent and SDS-PAGE was used to visualize the result ([@B13]). Two-dimensional gel electrophoresis (2D) was performed essentially as described ([@B32]). The resolved proteins were transferred onto a 0.45 μm polyvinylidene fluoride membrane (PVDF, Millipore). Rabbit polyclonal anti-ω~2~ and anti-RNAP-σ^A^ antibodies were obtained using standard techniques ([@B4]).

Far-western blotting was used to probe the direct interaction between ω~2~ and RNAP-σ^A^. The prey used were ω~2~ (1 μg), RNAP-σ^A^ (1 μg) and bovine serum albumin (BSA, 5 μg used as a control); these were resolved by SDS-PAGE and transferred to a PVDF membrane. The protein was renatured by incubation of the membrane in TBS containing 0.05% Tween, 10% glycerol and 5 mM β-mercaptoethanol followed by a blocking step with 5% skim milk, as described ([@B4]). The efficiency of the protein transfer was checked by Ponceau staining. The membrane was then incubated with 2 μg/ml of bait protein. To detect interactions between the bait and prey, rabbit polyclonal antibodies against the bait were employed as described ([@B33]).

Tryptic digestion of gel-purified protein bands, spotting onto the MALDI-targets, and MALDI-TOF-TOF of the spotted peptides were carried out as previously described ([@B34]).

*In vitro* transcription experiments {#SEC2-3}
------------------------------------

A 423-bp *P*~ω~ DNA sequence (5 nM) was used as a template for *in vitro* transcription run-off assays. 20 μl reaction mixtures containing 20 nM *B. subtilis* RNAP-σ^A^, variable concentrations of ω~2~, δ~2~ or both, 0.5 mM each of ATP, CTP, GTP and UTP plus 3000 Ci/mmol \[α-^32^P\]-UTP in buffer C (25 mM Tris-HCl, pH 8, 6 mM MgOAc, 5 mM DTT), and 20 U RNasin (Promega) were prepared. After 6 min of incubation at 37°C, the reactions were stopped by adding 10 μl of formamide. RNAs were analysed by 8% denaturing (d) polyacrylamide gel electrophoresis (PAGE), and autoradiographed. Chemical sequencing reactions of the purines were run in parallel to determine the sizes of the cDNAs.

Protein-DNA complexes {#SEC2-4}
---------------------

For electrophoretic mobility shift assays (EMSA), the 423-bp \[α^32^P\]-*P*~ω~ DNA (0.1 nM) was incubated either with a variety of concentrations of ω~2~, δ~2~ or RNAP-σ^A^ or with a constant concentration of one component and a range of concentrations of the others. Incubations were performed in buffer D (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM MgCl~2~) for 15 min at 37°C in a 20 μl reaction. Mixtures were subjected to 6% PAGE in 1xTAE at 4ºC. Gels were dried prior to autoradiographical analysis.

In order to obtain K~Dapp~ values from the EMSA experiments, the relative concentrations of free DNA and protein·DNA complexes were densitometrically determined under non-saturating conditions using differently exposed autoradiographs of the EMSA gels. The protein concentration needed to trap 50% of the free, labelled DNA containing the same molar concentration of heptads, in complexes is approximately equal to the K~Dapp~ under conditions where the DNA concentration is much lower than the K~Dapp~.

Reaction conditions similar to those used for EMSA were employed in footprinting experiments. The 423-bp \[α^32^P\]-*P*~ω~ DNA (1 nM) was incubated with variable protein concentrations and treated with DNaseI, as previously described ([@B4]). The samples were resolved by 6% dPAGE and the gel was dried prior to autoradiographical analysis. For KMnO~4~ footprinting, the samples were treated with 1 mM KMnO~4~ for 0.5 min at 37º C, after which the DNA was cleaved with piperidine ([@B35]).

RESULTS {#SEC3}
=======

RNAP-σ^A^ facilitates ω~2~·*P*~ω~ DNA complex formation {#SEC3-1}
-------------------------------------------------------

In order to unravel the mechanism of ω~2~-mediated regulation of *P*~ω~ utilization, the interaction of ω~2~ and/or RNAP-σ^A^ with *P*~ω~ DNA was assayed by EMSA (Figure [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). *P*~ω~ DNA has 7 discrete ω~2~ cognate sites. A 423-bp DNA segment containing *P*~ω~ bound ω~2~ with high affinity to form ω~2~·*P*~ω~ DNA also known as the C1 complex (K~Dapp~ of 6 ± 1.7 nM) (Figure [2C](#F2){ref-type="fig"} filled circles). When *P*~ω~ DNA was replaced with a non-specific DNA, the affinity of ω~2~ was low, with a K~Dapp~ \> 500 nM (data not shown) ([@B4]). This confirmed previously reported data indicating a high affinity of ω~2~ for *P*~copS~, *P*~δ~ and *P*~ω~ ([@B10]). In addition, binding was found to be cooperative (Figure [2C](#F2){ref-type="fig"}). *P*~ω~ also bound RNAP-σ^A^ with high affinity to form RNAP-σ^A^·*P*~ω~ DNA, also known as the RC1 complex (K~Dapp~ of 29.4 ± 9 nM, Figure [2C](#F2){ref-type="fig"} filled rombs).

![Cooperative binding of ω~2~ and RNAP-σ^A^ to *P*~ω~ DNA. (**A**) EMSA of (0.1 nM) 423-bp \[α^32^P\]-*P*~ω~ DNA incubated with 0.75 nM and 6 nM ω~2~ (lanes 2 and 3), increasing concentrations of RNAP-σ^A^ (1.9, 3.7, 7.5, 15, 30 and 60 nM, lanes 4--9), or fix ω~2~ (0.75 nM) and increasing concentrations of RNAP-σ^A^ (1.9--60 nM) (lanes 10--15) in buffer D. (**B**) EMSA of \[α^32^P\]-*P*~ω~ DNA with of 0.75 nM and 6 nM ω~2~ (lanes 9 and 10, respectively) or with 7.5 nM (lanes 1--7) or 15 nM (lanes 11--17) RNAP-σ^A^ and increasing concentrations of ω~2~ (0.19, 0.37, 0.75, 1.5, 3 and 6 nM) in buffer D. (**C**) Graph showing the percentage of *P*~ω~ DNA bound to the proteins based on densitometric data of bands from the above gels. The signals present in the protein-DNA complex and in the free-DNA (FD) were determined by densitometry. The data presented here are averages and standard deviations of the results of at least four independent experiments.](gkv788fig2){#F2}

In the presence of limiting ω~2~ (0.75 nM) concentrations, ω~2~·*P*~ω~ DNA complex formation was not observed (Figure [2A](#F2){ref-type="fig"}, lane 2 and [2C](#F2){ref-type="fig"} filled circles). Increased concentrations of RNAP-σ^A^ enhanced recruitment of ω~2~ to the promoter region by at least 8-fold. This was observed as an increase in the formation of high affinity C2 complexes. This effect was detected using limiting RNAP-σ^A^ concentrations (3.7 nM) (Figure [2A](#F2){ref-type="fig"}, lanes 11--15). The 'cooperative' binding leading to C2 complex formation could not be attributed to molecular crowding, because the BSA control did not function as a substitute for RNAP-σ^A^ (data not shown). The stable C2 and the transient C1 had a similar mobility. However, at higher concentrations of ω~2~, the mobility of C2 was even further diminished (Figure [2A](#F2){ref-type="fig"}, lanes 3 versus 11). The C1 complex had a half-life of \<1 min ([@B10]). The formation of the ω~2~·*P*~ω~ DNA complex was also enhanced at least 8-fold (K~Dapp~ of 0.6 ± 0.2 nM) when a fixed limiting concentration of RNAP-σ^A^ (∼4-fold below K~Dapp~) and increasing concentrations of ω~2~ were incubated with *P*~ω~ DNA (Figure [2B](#F2){ref-type="fig"}, lanes 1--6 and [2C](#F2){ref-type="fig"} open circles).

To distinguish cooperative binding from a mechanism whereby a protein--protein interaction preceded binding to *P*~ω~ DNA, the experiment was modified by doubling the concentration of RNAP (∼2-fold below K~Dapp~). In the presence of sub-stoichiometric concentrations of RNAP-σ^A^ (15 nM), the ω~2~·*P*~ω~ DNA complex formation became enhanced by at least 10-fold. This resulted in a stoichiometry of **∼**2 ω~2~/*P*~ω~ DNA (Figure [2B](#F2){ref-type="fig"}, lanes 12--17 and [2C](#F2){ref-type="fig"}, open circles). This is consistent with the known characteristics of ω~2~ binding to *P*~ω~ DNA which had a stoichiometry of **∼**1 ± 0.2 ω~2~ /heptad. The minimal ω~2~ binding site consisted of two contiguous heptads ([@B9]--[@B12]). It is therefore likely that ω~2~ interacts with RNAP-σ^A^, and that such an interaction induces a conformational change in the former that increases its apparent affinity for *P*~ω~ DNA. This favours the formation of the C2 complex. Meanwhile, in the absence of RNAP-σ^A^, ω~2~-bound to *P*~ω~ forms the C1 complex with an 8-fold lower apparent affinity (K~Dapp~ of 6 ± 1.7 nM).

A low concentration of ω~2~ facilitates the formation of the RNAP-σ^A^·*P*~ω~ DNA complex {#SEC3-2}
-----------------------------------------------------------------------------------------

Limiting concentrations of ω~2~ enhanced the recruitment of RNAP-σ^A^ to *P*~ω~ DNA (Figure [2B](#F2){ref-type="fig"}, lanes 1--3 and 12--14). 7.5 nM RNAP-σ^A^ was the limiting concentration of RNAP-σ^A^ necessary to detect the RC2 complex (RNAP-σ^A^·*P*~ω~ DNA·ω~2~). This was ∼4-fold less than the K~Dapp~ (Figure [2C](#F2){ref-type="fig"} open versus filled rombs). It is therefore likely that ω~2~ interacts with RNAP-σ^A^ and facilitates a functional transition of RNAP-σ^A^. To test whether or not ω~2~ and RNAP-σ^A^ co-localize in a RC2 complex, ω~2~ and RNAP-σ^A^ were incubated with *P*~ω~ DNA and subjected to DNase I footprinting analysis. The ω~2~ protein protected nucleotides −22 to −75 (with a numbering relative to the +1 transcription start site) (Supplementary Figure S2A, lanes 4--5). Meanwhile, RNAP-σ^A^ made a weak but significant contact with a segment located between positions −53 to +18. In parallel, a clearly hypersensitive site appeared at position −37. This is denoted by a dotted line square in Supplementary Figure S2A, lanes 6--9. Addition of a limiting concentration of ω~2~ of ∼4-fold below the K~Dapp~ resulted in the disappearance of the hypersensitive site. This effect was reversed upon increasing the concentration of RNAP-σ^A^ (Supplementary Figure S2A, lanes 10--13). It was also reversed by increasing the concentration of ω~2~ to ∼2-fold below the K~Dapp~ (Supplementary Figure S2B, lanes 13--16). Judging by the fading out of the hypersensitive site at position −37, it is likely that limiting concentrations of ω~2~ or RNAP-σ^A^ reposition RNAP-σ^A^ on the *P*~ω~ DNA.

Addition of sub- to stoichiometric concentrations of ω~2~ led to an increase in the formation of RC2 (RNAP-σ^A^·*P*~ω~ DNA·ω~2~) complex formation by at least 3-fold (K~Dapp~ of 9.5 ± 3.4 nM) (Figure [2B](#F2){ref-type="fig"}, lane 17 and [2C](#F2){ref-type="fig"}, open rombs). Equilibrium was thus reached at about ∼4 ω~2~/RNAP-σ^A^/*P*~ω~ DNA. These results suggested that there was not a sufficient number of ω~2~ molecules to occupy the seven *P*~ω~ heptads. Since ω~2~ binds with a slightly higher affinity and cooperativity to heptad pairs in the →← than in the →→ orientation ([@B10]), we favour the hypothesis that the →← heptads at positions −41 to −27, which overlap the −35 element and its neighbours, might be the ones recruited by ω~2~ to interact with RNAP-σ^A^. Indeed, sub- to stoichiometric concentrations of ω~2~ bound to *P*~ω~ DNA protected this region from DNase I attack (Supplementary Figure S2B, lanes 3--6). Meanwhile at stoichiometric concentrations RNAP-σ^A^ made weak but extensive contacts with the upstream region, which had the same exposed hypersensitive site at position −37 (Supplementary Figure S2B, lanes 8--11). At sub-stoichiometric concentrations of ω~2~, RNAP-σ^A^ made extensive contacts with the upstream −35 region. The hypersensitive site at position −37 remained exposed (Supplementary Figure S2B, lanes 13--16). This hypersensitive site was lost in the presence of stoichiometric concentrations of ω~2~. Meanwhile, protection from DNase I was only observed in a stretch of DNA between positions −72 to −21 (Supplementary Figure S2B, lanes 18--21). In light of these results, it is likely that: (i) ω~2~ physically interacts with RNAP-σ^A^; and (ii) depending on the experimental conditions, ω~2~ either displaces RNAP-σ^A^ from or re-localises with it on *P*~ω~ DNA.

The interaction between ω~2~ and δ~2~ does not affect RNAP-σ^A^ binding to *P*~ω~ DNA {#SEC3-3}
-------------------------------------------------------------------------------------

Protein δ~2~ bound non-specific DNA (K~Dapp~ 130 ± 20 nM) in the presence of ATP. This lead to the formation of the DC complex (Supplementary Figure S3A, lanes 6--8) ([@B13]). Binding of δ~2~ to non-specific DNA increased 3 to 4-fold in the presence of ω~2~·*P*~ω~ DNA (Supplementary Figure S3A, lanes 10--12, and S3C, empty squares). In the absence of ATP, δ~2~ only augmented the affinity of ω~2~ for *P*~ω~ DNA by 6- to 10-fold (C2 formation) (Supplementary Figure S3B, lanes 10--15 and Figure [1E](#F1){ref-type="fig"}, condition 2). This was consistent with observations that: (i) the presence of apo-δ~2~ decreased the off rate of ω~2~ from ω~2~·*P*~ω~ DNA complexes; (ii) the presence of ω~2~ significantly increased the half-life of the δ~2~·*P*~ω~ DNA complexes in the presence of ATP ([@B13]); and (iii) upon interacting with δ~2~, ω~2~ that is bound to *P*~ω~ DNA (*parS*) undergoes a structural transition that might involve the formation of an α-helix in the normally unstructured NTD (see 15).

To test whether the interaction of ω~2~ with δ~2~ or RNAP-σ^A^ are mutually exclusive or if the interaction between δ~2~ and ω~2~ affects ω~2~-mediated recruitment onto the *P*~ω~ DNA of RNAP-σ^A^, limiting concentrations of ω~2~ (∼8-fold below K~Dapp~) and/or RNAP-σ^A^ (∼4-fold below K~Dapp~) were incubated with increasing δ~2~ concentrations and subjected to an EMSA (Supplementary Figure S3A and S3B, lanes 10--15). In the presence of ATP, assembly of the ternary C3 complex (δ~2~·ω~2~·*P*~ω~ DNA) occurred (Supplementary Figure S3A, lanes 10--15). However, these results were not observed when ATP was omitted (Supplementary Figure S3B, lanes 10--15). Meanwhile, assembly of the ternary RC2 complex (ω~2~·*P*~ω~·RNAP-σ^A^) was observed without ATP (Supplementary Figure S3A and S3B, lanes 13--15). Finally, in the presence of ATP, δ~2~ did not significantly affect the affinity of RNAP-σ^A^ for *P*~ω~ in the presence of ATP (Supplementary Figure S3D, lanes 8--16).

Whether ω~2~ functions as an activator or repressor is dependent on its concentration {#SEC3-4}
-------------------------------------------------------------------------------------

Protein ω~2~ binds *P~copS~, P*~δ~ and *P*~ω~ DNA with a stoichiometry of **∼**1 ± 0.2 ω~2~ /heptad ([@B9],[@B12]). We previously mapped the pSM19035 transcription start sites of *P~copS~, P*~δ~ and *P*~ω~ (see Supplementary Figure S1). In that study, we showed that 7.5 -- 15 ω~2~/*P~copS~, P*~δ~ or *P*~ω~ DNA represses promoter utilization ([@B4]). To gain insight into the mechanism by which ω~2~ regulates promoter utilization, we performed transcription run-off experiments using RNAP-σ^A^ (at K~Dapp~) in the presence of increasing concentrations of ω~2~. Linear *P*~ω~ DNA containing seven heptads was used as the template (Figure [3A](#F3){ref-type="fig"}). As expected, 282-nt mRNA transcripts were produced (Figure [3B](#F3){ref-type="fig"}, lane 1). This result is consistent with the location of the initial nucleotides of *P*~ω~, which had been previously mapped *in vivo* ([@B4]).

![RNAP-σ^A^ mediated transcription as a function of the presence or absence of ω~2~ and δ~2.~ (**A**) A 423-bp DNA segment containing *P*~ω~ is depicted. The heptads are labelled and their relative orientations are represented by arrows. The positions of the −35 and −10 elements are indicated with filled rectangles. The transcription start site is represented with a solid arrow bent 90º. The ω and part of the ϵ gene are indicated as well. (**B**) Run-off experiments: the 423-bp *P*~ω~ DNA (5 nM) was the template in an *in vitro* transcription experiment using \[α^32^P\]-UTP in buffer C. RNAP-σ^A^ (20 nM) was present in all cases. Results shown for transcription in the absence (lane 1) or presence of increasing concentrations of either ω~2~ (3.7, 7.5, 15, 30 and 60 nM, lanes 2--6) or δ~2~ (37, 75, 150, 300 nM, lanes 7--10). Also shown are results of assays in the presence of either 150 or 300 nM δ~2~ (lanes 11--16 or 17--22 respectively) with increasing concentrations of ω~2~. (**C**) Quantification of mRNA synthesis in the presence of increasing concentrations ω~2~ alone or in the presence of a fix concentration of δ~2~ (150 or 300 nM). Shown here are the analysed results from five independent experiments.](gkv788fig3){#F3}

In the presence of limiting concentrations of ω~2~ (0.9 and 1.8 ω~2~/*P*~ω~ DNA), transcriptional activation was modest (1.4- to 1.7-fold), but reproducible (Figure [3B](#F3){ref-type="fig"}, lanes 2--4, and [3C](#F3){ref-type="fig"}). Protein ω~2~ might preferentially bind the heptads of the *P*~ω~ DNA overlapping the −35 element. To test this hypothesis, the heptad 7, heptads 6 plus 7 and, as controls, heptads 1 or 1 plus 2 were inactivated (Figure [3A](#F3){ref-type="fig"}). As documented in Supplemental material Annex 1, the selective occupancy of heptads 6 and 7 versus 1 and 2 plays a minor role, if at all, in ω~2~-mediated activation of *P*~ω~ utilization.

Stoichiometric concentrations of 7.5 ω~2~/*P*~ω~ DNA inhibited *P*~ω~ expression by 4- to 8-fold. At slightly saturating conditions (15 ω~2~/*P*~ω~ DNA or ∼2 ω~2~/heptad) mRNA synthesis halted completely (\>50-fold) (Figure [3B](#F3){ref-type="fig"}, lanes 5 and 6). Concentrations of ω~2~ equal to or higher than those required to repress *P*~ω~ did not affect the expression of the unrelated promoter (*P*~cro~ of phage A2) (data not shown). We could hence rule out RNase contamination or any other nonspecific effect as the reason for the lack of RNA synthesis. It is therefore likely that ω~2~ has a dual activity: at limiting concentrations it facilitates the *P*~ω~-RNAP-σ^A^ interaction, but at stoichiometric concentrations and higher, transcriptional repression results.

Limiting concentrations of ω~2~ facilitate the transition from RP~C~ to RP~O~ and stoichiometric concentrations of ω~2~ block this shift {#SEC3-5}
----------------------------------------------------------------------------------------------------------------------------------------

To discern the mechanism of ω~2~-mediated repression of *P*~ω~, we investigated RP~O~ complex formation and abortive initiation (RP~INIT~) effects in the presence of variable concentrations of ω~2~. For this, we carried out KMnO~4~ footprinting assays in the presence or absence of GTP and ATP. Up to 9-nt long transcripts were synthesized in these assays (see Supplementary Figure S1).

No oxidized thymines were detected on the template strand after 50 s of KMnO~4~ exposure (Figure [4](#F4){ref-type="fig"}, lanes 1, 7, 13 and 19). In the absence of nucleotide precursors, the position in the *P*~ω~ DNA of non-base-paired thymines preferentially attacked by KMnO~4~ revealed that RNAP-σ^A^ promoted spontaneous formation of a RP~O~ complex centred at position −11T and −10T of the template strand, rather than an extended *P* melting of ∼14-bp (from −12 to +2) (Figure [4](#F4){ref-type="fig"}, lanes 2 and 8). KMnO~4~-promoted cleavage of RNAP-σ^A^ bound template increased in the presence of sub-stoichiometric concentrations of ω~2~ (Figure [4](#F4){ref-type="fig"}, Supplementary Figure S4A, lanes 3--4). Cleavage was inhibited at saturating concentrations of ω~2~ (Figure [4](#F4){ref-type="fig"}, Supplementary Figure S4A, lanes 5--6). However, increased cleavage was not observed when sub-stoichiometric ω~2~ concentrations were added to reactions containing RNAP-σ^A^, i.e. with a pre-formed RP~O~ (Figure [4](#F4){ref-type="fig"}, lanes 9--10).

![Effect of ω~2~ on the formation of RP~O~ at *P*~ω~. The 423-bp \[α^32^P\]-*P*~ω~ DNA (1 nM) was pre-incubated with increasing concentrations of ω~2~ (7.5, 15, 30 and 60 nM; lanes 2--6 and 14--18) or with 7.5 nM RNAP-σ^A^ (lanes 8--12 and 20--24) in buffer C. A second protein was added along with the initiating nucleotides, GTP and ATP (as indicated). DNA melting was probed by KMnO~4~ footprinting as a way of observing the open complex. The positions hypersensitive to KMnO~4~ are labelled (RP~O~ and RP~INIT~) and depicted at the bottom of the figure. The coordinates are relative to the transcription start point. Chemical sequencing reactions for purines (G +A) are shown and the relevant regions of *P*~ω~ depicted to the right of the figure.](gkv788fig4){#F4}

In the presence of ATP and GTP, RNAP-σ^A^ promoted abortive initiation and synthesis of up to 9-nt oligonucleotides (RP~INIT~) (data not shown). KMnO~4~ attack revealed the formation of an extended single-stranded bubble that cleaved at positions −10T, −6T, −5T and +7T (Figure [4](#F4){ref-type="fig"}, lanes 14 and 20). When ω~2~ and RNAP-σ^A^ were left out, no cleavage was observed (Figure [4](#F4){ref-type="fig"}, lanes 13 and 19). Pre-incubation of *P*~ω~ DNA with sub-saturating concentrations of ω~2~ followed by addition of RNAP-σ^A^ resulted in a significant increase (∼2.5-fold) in KMnO~4~ cleavage (Figure [4](#F4){ref-type="fig"}, lane 15 and 21 and Supplementary Figure S4B). At higher ω~2~ concentrations, the reaction became inhibited (Figure [4](#F4){ref-type="fig"}, lanes 17--18, Supplementary Figure S4A, lanes 15--16 and S4B). However, RNAP-σ^A^-mediated RP~O~ formation was hardly, if at all, affected by addition of ω~2~ to the preformed RNAP-σ^A^·*P*~ω~ complexes (Figure [4](#F4){ref-type="fig"}, lanes 21--24).

Altogether, these data suggest that: (i) ω~2~ does not repress transcription by sterically hindering the interaction between RNAP-σ^A^ and *P*~ω~ DNA; (ii) in the absence of the nucleotides cofactors, RNAP-σ^A^ forms a short RP~O~ complex on *P*~ω~ centred at position −11T and −10T; (iii) limiting concentrations of ω~2~ push RP~O~ to begin RNA synthesis (RP~INIT~); (iv) stoichiometric concentrations of ω~2~ inhibit RP~O~ formation, with ω~2~ blocking the isomerization of RP~C~ to RP~O~; and (v) ω~2~ has no apparent effect on pre-formed RP~O~. We cannot rule out that saturating concentrations of ω~2~ may inhibit transcription by steric occlusion or relocation of RNAP-σ^A^ on preformed ω~2~·*P*~ω~ complexes (see Supplementary Figure S2B, lanes 18--21).

Protein δ~2~ represses *P*~ω~ expression {#SEC3-6}
----------------------------------------

In the presence of ATP, δ~2~ binds non-specific DNA with a K~Dapp~ = 130 ± 20 nM) (Supplementary Figure S3A, lanes 6--8) ([@B13]). As shown in Figure [3B](#F3){ref-type="fig"} (lane 1 versus 7--10), limiting concentrations of δ~2~ did not affect transcription of *P*~ω~. Meanwhile, stoichiometric and saturating concentrations of δ~2~ inhibited *P*~ω~ utilization (2.8- to 3.5-fold). Ultimately utilization was blocked entirely.

To unravel the mechanism of δ~2~-mediated *P*~ω~ repression, KMnO~4~ cleavage experiments were performed. Pre-incubation of *P*~ω~ DNA with sub-stoichiometric to stoichiometric concentrations of δ~2~ followed by addition of RNAP-σ^A^ did not alter the pattern of KMnO~4~ cleavage obtained in the absence of δ~2~ (Supplementary Figure S5, lanes 1--4 versus 5). This result suggested that δ~2~ represses *P*~ω~ (Figure [3](#F3){ref-type="fig"}, lanes 9--10) through gene silencing, i.e. halting RNAP elongation (Figure [3](#F3){ref-type="fig"}, lanes 9--10). The same model has been as proposed for other ParAB systems to which δ~2~ and ω~2~ belong ([@B36],[@B37]). This model is also consistent with the observation that non-specific binding of δ~2~ to DNA might occlude RNAP-σ^A^ clearance or affect RNAP mediated elongation.

Protein δ~2~ acts as a co-activator of *P*~ω~ expression {#SEC3-7}
--------------------------------------------------------

Upon coming into contact with ω~2~·*P*~ω~ complexes, δ~2~ protein bound to non-specific DNA relocates onto ω~2~·*P*~ω~ to form ternary C3 complexes (Figure [1E](#F1){ref-type="fig"}, condition 3) ([@B12]). The C3 complex is characterized by a longer half-life than is C1 (ω~2~·*P*~ω~ DNA). To test whether C3 might affect transcription, *P*~ω~ run-off experiments were performed (Figure [3B](#F3){ref-type="fig"}, lanes 11--22). At 150 nM, a concentration of δ~2~ equivalent to its K~Dapp~, addition of limiting concentrations of ω~2~ (1.8 to 3.7 ω~2~/*P*~ω~ DNA) significantly stimulated mRNA synthesis by \>3-fold (Figure [3B](#F3){ref-type="fig"}, lanes 12--14 and [3C](#F3){ref-type="fig"}). Nevertheless, synthesis was attenuated and ultimately blocked at higher concentrations of ω~2~ (Figure [3B](#F3){ref-type="fig"}, lanes 15--16).

At 300 nM, δ~2~ significantly reduced *P*~ω~ utilization by ∼14-fold (Figure [3B](#F3){ref-type="fig"}, lanes 1 versus 17). Addition of limiting concentrations of ω~2~ (1.8--3.7 ω~2~/*P*~ω~ DNA or 0.2--0.5 ω~2~/heptad) significantly stimulated *P*~ω~ dependent mRNA synthesis by \>6-fold (Figure [3B](#F3){ref-type="fig"}, lanes 18--20, and [3C](#F3){ref-type="fig"}). As expected, ω~2~ blocked *P*~ω~ utilization when used at the slightly saturating concentrations of 15 ω~2~/*P*~ω~ DNA (Figure [3B](#F3){ref-type="fig"}, lane 22). It is likely, therefore, that whether ω~2~ acts as a transcriptional activator or a repressor hinges on its concentration (Figure [3C](#F3){ref-type="fig"}). Moreover, while by itself repressing *P*~ω~ utilization, δ~2~ apparently behaves as a transcriptional co-activator. This is consistent with the observations that: i) the half-life of ω~2~·*P*~ω~ complex increased ∼30-fold in the presence of δ~2~ ([@B10],[@B13]); and ii) upon interacting with δ~2~, ω~2~ bound to *P*~ω~ DNA, a rearrangement of its unstructured NTD occurs (see 15).

Protein ω~2~ interacts with the NH~2~-terminal half of the RNAP-σ^A^ β' subunit {#SEC3-8}
-------------------------------------------------------------------------------

RNAP-σ^A^ and ω~2~ cooperatively bind *P*~ω~ DNA cooperatively and create higher-order nucleoprotein complexes that reflect the combinatorial control of gene expression (Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}). This effect is likely attributed to direct protein--protein interactions between adjacent DNA-binding factors that promote the assembly of higher-order complexes. To determine whether or not RNAP-σ^A^ and ω~2~ physically interacted, RNAP-σ^A^ was bound to a Ni^2+^ agarose column through coordination with the C-terminal histidine tag of its β' subunit ([@B30]). The RNAP-σ^A^-bound matrix retained ω~2~, even in the absence of *P*~ω~ DNA. These proteins also co-eluted from the matrix during an elution step (Supplementary Figure S6).

Initial identification of the RNAP-σ^A^ subunit(s) responsible for association to ω~2~ was achieved by carrying out far-western blots of RNAP-σ^A^, ω~2~ and BSA as control. These proteins were resolved by SDS-PAGE under conditions under which the small ω protein (7.9 kDa) migrated with the front. After renaturation of prey proteins and a membrane blocking step, the bait, ω~2~, was added. Protein--protein interactions were detected using anti-ω~2~ polyclonal antibodies. As expected, ω~2~ interacted with itself and also with the co-migrating β and/or β' subunits of RNAP-σ^A^. No other subunits gave a signal (Figure [5A](#F5){ref-type="fig"}). Due to a similarity in mass, β (133.6 kDa) and β' (134.2 kDa) subunits could not be distinguished. We therefore took advantage of the fact that all *B. subtilis* RNAP-σ^A^ subunits, except for β' (pI 8.8), have acidic pIs and repeated the far-western experiments, this time using two-dimensional (2D)-PAGE. Protein ω~2~ interacted with β' and several proteins in unexpected spots (termed 1--2, 3--4 and 5). These had masses of ∼34 kDa and were located in the basic region of the gel (Figure [5B](#F5){ref-type="fig"}, Ab-anti ω~2~ condition). Corresponding polypeptides were extracted from the gel, subjected to mass spectrometry analysis, and identified as RNAP-σ^A^ β' subunit NTDs with slight variations in the C-termini (Figure [5C](#F5){ref-type="fig"}). Taking into account the sizes observed, it was assumed that the Sw2 structural module (residues 316--342) was missing from these NTD variants of the β' subunit.

![Far-western blotting of ω~2~ and RNAP-σ^A^. (**A**) 1 μg ω~2~, 1 μg RNAP-σ^A^ or 5 μg BSA (as control) were resolved by SDS-PAGE and either stained with Coomasie blue or transferred onto nitrocellulose membranes. Membranes underwent a renaturing step and incubated with the specific ω~2~ and RNAP-σ^A^ antibodies (Ab). (**B**) 1 μg RNAP-σ^A^ was resolved by iso-electric focusing in a pH 3--11 gradient followed by an SDS-PAGE. Protein was then transferred to a membrane, renatured, incubated with the ω~2~ bait and highlighted with either Ab-anti ω~2~ or Ab-anti RNAP-σ^A^. (**C**) Basic, ∼34 kDa polypeptides (1--5) that had reacted with Ab-anti ω~2~ were gel purified and identified by mass spectrometry. The regions identified are shown in this figure. The sequence coverage was \> 40%.](gkv788fig5){#F5}

The central and C-terminal regions of ω~2~ appears not to interact with RNAP-σ^A^ {#SEC3-9}
---------------------------------------------------------------------------------

The ω~2~ protein has three functional regions: (i) the unstructured NTD (residues 1--24), which is essential for the ω~2~·δ~2~ interaction ([@B11],[@B15]); (ii) the β-sheet domain (residues 28--32), which is required for ω~2~ recognition of its cognate DNA site ([@B9],[@B14]); and (iii) the α-helix α1 (residues 34--46) which, in concert with the α2 helix (residues 51--64) contributes to monomer-monomer and dimer-dimer interfaces ([@B8],[@B9]). The function, if any, of the C-terminal region (residues 65--71) is unknown ([@B7],[@B8]).

Significantly, the 79-residue long ω2 (9.0 kDa) shares a 98% identity with the 71-residue ω for the first 55 residues (Supplemental material Annex 2). However, they only share an 18% identity in the last 24 residues (Supplementary Figure S7A). The ω2 protein repressed *P*~δ~ utilization *in vivo* nearly as efficiently as wt ω~2~ (Supplemental material Annex 2, Supplementary Figure S7B). Similar results were observed when the *P*~δ~*-lacZ* fusion was replaced by the *P*~ω~*-lacZ* fusion (data not shown). Furthermore, plasmid-borne ω2 and δ genes which were transcribed from *P*~ω~ (*parS*2) and *P*~δ~ (*parS*1) (Figure [1A](#F1){ref-type="fig"}), were necessary and sufficient for stabilizing of an otherwise unstable plasmid in *B. subtilis* cells ([@B38], our unpublished results). It is likely that: (i) the dimer is the functional unit of ω2; (ii) ω~2~2 interacts with δ~2~ just like ω~2~; and (iii) the different C-terminal domains of ω and ω2 are not involved in gene repression.

Protein docking experiments predicted that the unstructured ω NTD folded into an α-helical structure that interacted with the β' NTD of RNAP-σ^A^ (Supplementary Figure S8). In contrast, several charged amino acids located in the coiled region between the α-helices α1 and α2 (residues 47--52) and in the α2 helix itself (residues 51--64) could make contacts with the oppositely charged residues in the β' subunit of RNAP-σ^A^. To test this hypothesis (Supplemental material Annex 3), the charged residues that were accessible in these domains, K52, E53, D56, R64 and K70, were replaced with alanine. Subsequently, the *in vivo* behaviour of these mutants was investigated (Supplemental material Annex 3). With the exception of ωD56A, the ω mutant variants repressed *P*~δ~ transcription *in vivo* as efficiently as wt ω~2~ (Supplementary Figure S7B) (Supplemental material Annex 3). The D56A mutant only reduced *P*~δ~ transcription ∼6-fold. As described in Supplementary Annex 3, purified ωD56A also formed dimers, albeit in a far smaller proportion than wt ω~2~ (Supplementary Figure S7C). Since in the dimeric form of ω, the β-sheet domain adopts an antiparallel configuration before binding *P*~ω~, the primary defect of ωD56A might be a poor ability to dimerize. Therefore, it was not further analysed. It would be very interesting to determine whether or not the ω~2~ NTD can, by itself recruit RNAP-σ^A^ to the ω~2~·*P*~ω~ DNA complex.

DISCUSSION {#SEC4}
==========

Direct contacts between ω~2~ and RNAP-σ^A^ stimulate RP~C~ complex formation and its subsequent isomerization to RP~O~. This appears to be the mechanism by which limiting concentrations of ω~2~ activate *P*~ω~ transcription. This process is further enhanced by δ~2~ (Figure [3B](#F3){ref-type="fig"}). However, stoichiometric concentrations of ω~2~ have the opposite effect: here the recruited RNAP-σ^A^ inefficiently isomerizes into RP~O~ and represses *P*~ω~ or *P*~δ~ transcription both *in vivo* and *in vitro*. It would be highly interesting to determine whether or not ω~2~ functions as an activator to repressor switch of *P~copS~*. However, preliminary results indicate that ω~2~·*P~copS~* DNA forms a ternary complex with RNAP-σ^A^ and that ω~2~ regulates transcription through a mechanism that does not exclude the RNAP-σ^A^ from the RP~C~ ([@B4]).

The dual activity of the ω~2~ regulator {#SEC4-1}
---------------------------------------

Plasmid-encoded ω~2~, from Gram-positive cocci, is the only one out of the more than 2000 RHH~2~ proteins that can either activate or repress the utilization of a single promoter (*P*~ω~) in a concentration-dependent manner. This is true at least in a simplified *in vitro* system. The majority of RHH~2~ proteins are predicted to be transcriptional repressors ([@B39]). However, four of them act both as activators and as repressors. These are: a P22-Arc variant, Mer, AmrZ \[AlgZ\] and NikR. They bind to a variety of promoters, functioning as repressors for some while behaving as activators for others ([@B40]--[@B43]). In the case of other putative regulators, various metal cofactors and different stoichiometries might also influence the effect they have on promoter functioning ([@B40]--[@B43]).

The activator to repressor switch function of ω~2~ appears to be managed by the diverse modes of ω~2~ binding to the operator region of *P*~ω~. These modes of binding have distinct effects on the initial activity of RNAP-σ^A^. Under limiting concentrations, ω~2~ promotes RNAP-σ^A^ binding to operator sequences that overlap the −35 sequence. This results in the stimulation of RP~C~ formation and in an increase in the rate of isomerization from RP~C~ to RP~O~. It is thus likely that: (i) ω~2~ increases the local concentration of both proteins, leading to a ternary ω~2~·*P*~ω~·RNAP-σ^A^ complex; (ii) this ternary complex facilitates the rate of isomerization from RP~C~ to RP~O~ and increases *P*~ω~ dependent mRNA synthesis; and (iii) δ~2~ may act as a co-activator by increasing the half-life of ω~2~*·P*~ω~ DNA complexes (see 13).

With stoichiometric concentrations of ω~2~ full operator occupancy was achieved, and a different outcome was observed. Under these conditions, ω~2~ assembles into a left-handed matrix that wraps around right-handed, straight *P*~ω~ DNA (see Figure [1B](#F1){ref-type="fig"}). This assembly makes *P*~ω~ DNA accessible to RNAP-σ^A^ (RP~C~ formation), while simultaneously inhibiting isomerization to RP~O~ (transcriptional repression) (Figure [4](#F4){ref-type="fig"}, lanes 17--18). *In vitro*, we observed that δ~2~ contributed to *P*~δ~ repression (Figure [3B](#F3){ref-type="fig"}), and the presence of both ω~2~ and δ~2~ transcriptional repression of *P*~δ~ and *P*~ω~ was elevated *in vivo* with respect to wt ω~2~ alone (Supplementary Figure S7B, data not shown). When stoichiometric concentrations of ω~2~ were added to preformed RP~O~ complexes, a moderate effect on *P*~ω~ utilization was observed (see Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). This suggested that RNAP-σ^A^ transcription was influenced by ω~2~ that was bound to its cognate promoters. In sum, we describe here a previously uncharacterized mechanism of transcription regulation in bacteria belonging to the phylum Firmicutes.

Several different models can be considered in order to explain the specific transcriptional repression resulting from the full occupancy of the operator sequences by ω~2~: (i) relocation of RNAP-σ^A^ to a position unfavourable for efficient RP~O~ formation; (ii) 'locking' RNAP-σ^A^ into a conformation unfavourable for RP~O~ formation; (iii) blocking the interaction between the β' NTD and the DNA, which may be an essential step for RP~O~ formation; and (iv) inhibition of RNAP-σ^A^ mediated transcription by hindering any putative upstream element. We favour the first model because RP~C~ formation is stimulated by the interaction between ω~2~ and RNAP-σ^A^, while the subsequent isomerization step producing stable RP~O~ (through the unstable intermediate, RP~I~) becomes inhibited. Also consistent with this model is the fact that ω~2~ establishes interactions with operator sites when RNAP-σ^A^ is already bound to *P*~ω~ DNA. Meanwhile, ω~2~ fails to inhibit pre-formed RP~O~, Also in line with this model is the observation that, in the presence of limiting amounts of ω~2~ bound to *P*~ω~ DNA, RNAP-σ^A^ moves onto *P*~ω~ DNA (Supplementary Figure S2A), and that while under saturating concentrations of ω~2~, RNAP-σ^A^ moves off of *P*~ω~ DNA (Supplementary Figure S2B).

The interplay between the ω~2~ regulator and the β' subunit of RNAP holoenzyme {#SEC4-2}
------------------------------------------------------------------------------

The work presented here establishes that ω~2~ is a global regulator of plasmid biology through its effect on replication, faithful partitioning and better-than random segregation (see Introduction). Importantly, ω~2~ represents an exception to the accepted prokaryotic transcription regulation paradigm, which asserts that, there are proteins that can act as either activators or repressors, but that the same protein cannot act as both. Since ω~2~ regulates the expression of plasmid encoded genes that are harboured in different Firmicutes bacteria, it presumably recognizes the RNAP β' NTD of all of them. This recognition might be limited to the first 316 amino acids, the length of the shortest polypeptide of the β' subunit that binds ω~2~ (Figure [5B](#F5){ref-type="fig"}). This would not be surprising because the β' subunits of all Firmicutes share a high degree of sequence identity. Consistent with this, ω~2~ does not regulate transcription of a genetically distant bacterium (e.g. *E. coli*) ([@B16]). These facts imply that the regions of the Firmicutes β' subunits that show a significant degree of sequence divergence are not involved in ω~2~ binding, such as residues 124--165 and 178--208 (22% and 13%, respectively). Presumably, residues 260--271, which match almost perfectly between the β' subunits of *E. coli* and *B. subtilis*, is a region also not involved in ω~2~ binding.

Few proteins have been observed to interact with the RNAP β' subunit. Most of these are encoded by proteobacterial phages. The phage Xp10-p7 factor interacts with the first 10 residues of the NTD of β' ([@B44]). The Mu-C protein binds to part of region F (b7) ([@B45]). T7-Gp2 recognizes part of the jaw (b9-b10) and σ 1.1 domains ([@B46],[@B47]). And lastly, N4-SSB interacts with part of region H (b11) at the CTD ([@B48]). These regulators do not share a specific target domain and have different modes of action: N4-SSB and Mu-C specifically act as transcription activators ([@B45],[@B48]), while T7-Gp2 and Xp10-p7 are repressors ([@B44],[@B46]). In contrast, ω~2~ has a dual function (Figure [3B](#F3){ref-type="fig"}). Of these regulators, only T7-Gp2, Xp10-p7, and ω~2~ act during the early stages of RNAP-σ isomerization. Meanwhile, T7-Gp2 and Xp10-p7 directly interact with RNAP-σ rather than binding to *P* DNA as does ω~2~ ([@B44],[@B46],[@B47]).

Biological implication of ω~2~-mediated transcription regulation {#SEC4-3}
----------------------------------------------------------------

A growing number of plasmid-encoded genetic determinants for resistance to diverse antimicrobials among streptococci, enterococci and staphylococci has been shown to be regulated by ω-like cofactors. They act either as part of the ωϵζ operon or on their own as part of the ω cassette (ω or ω2 genes) ([@B1]). In conjunction with δ~2~ and RNAP-σ, the biological role of ω~2~ as a dual regulator is to control vital plasmid functions in Firmicutes. It corrects the downward fluctuations in plasmid copy number through regulation of the synthesis of CopS (also termed CopF, CopR). CopS is a repressor of the initiator RepS (also termed RepE, RepR) protein. ω~2~ also controls the synthesis of the toxin-antitoxin module, which in turn restricts the survival of plasmid-free segregants. The ω~2~ protein mediates the synthesis of the partition system by regulating the expression of δ~2~ and ω~2~. Protein ω~2~2 manages the expression of the *ermB* gene ([@B4],[@B16],[@B49]). With the help of δ~2~ (the ParA ATPase), the ω~2~ (the ParB centromere binding) protein also safeguards plasmid faithful segregation via the ParAB system. The regulation of Firmicutes RNAP-σ^A^ by the ω cassette is a newly characterized mechanism through which bacterial transcription of a large number of antibiotic resistance genes is regulated.
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